Herbalife (NYSE:HLF) Azioni

Herbalife

Herbalife Nutrition

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

Scopri le tre azioni su cui gli insider stanno investendo massicciamente e le motivazioni dietro questi acquisti strategici.

Le 3 azioni su cui gli insider scommettono forte: ecco perché

Herbalife Ltd

HONG LEONG BANK BHD by Hong Leong Bank BHD

HONG LEONG FINCL GRP ORD by Hong Leong Financial Group BHD

Hong Leong Financial Group Bhd

HALFORDS GROUP PLC ORD by Halfords Group Plc

Halfords Group PLC

HALFORDS GROUP UNSP/ADR by Halfords Group Plc

HelloFresh SE

HILTON FOOD GROUP ADR by HILTON FOOD GROUP PLC

Hilton Food Group PLC

HOME LOAN FINCL CORP by Home Loan Financial Corp.

Home Loan Financial Corp

DA Davidson analyst Linda Bolton Weiser upgrades Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) from Neutral to Buy and raises the price target from $7.5 to $14.

News

Upgrades

Price Target

Analyst Ratings

DA Davidson Upgrades Herbalife to Buy, Raises Price Target to $14

Herbalife Announces Acquisition Of Pro2col, Pruvit, And 51% Stake in Link BioSciences, Terms Not Disclosed

Earnings

AAOI

ABEV

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

DA Davidson analyst Linda Bolton Weiser maintains Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) with a Neutral and maintains $7.5 price target.

DA Davidson Maintains Neutral on Herbalife, Maintains $7.5 Price Target

U.S. stocks were lower, with the Dow Jones falling over 1% on Thursday.
Shares of Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) rose sharply during Thursday's session after the company reported third-quarter financial results and beat its adjusted EPADS and <a href="https://www.benzinga.com/news/earnings/25/02/43846533/alibaba-q3-earnings-revenue-and-eps-beat-eyes-global-e-commerce-profitability-in-fy25-increase-investments-in-ai">revenue estimates</a>.
The Jack Ma co-founded e-commerce giant reported fiscal third-quarter 2024 revenue growth of 8% year-on-year to $38.38 billion, beating the analyst consensus estimate of $38.19 billion. Adjusted earnings per ADS of $2.93 beat the analyst consensus estimate of $2.66. Adjusted net income rose 7% Y/Y to $7 billion.
Alibaba Group shares jumped 9.5% to $137.77 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Herbalife Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) shares jumped 42.5% to $8.01 after the company reported fourth-quarter EPS and revenue above estimates.</li>
<li>Unity Software Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) gained 26.6% to $27.19 after the company reported better-than-expected quarterly financial results.</li>
<li>Pediatrix Medical Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) rose 20.5% to $17.01 after the company reported better-than-expected quarterly financial results.</li>
<li>FTAI Aviation Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) gained 13.8% to $143.11 after the company determined that allegations from recent short seller reports were without merit and said it expects to file its 10-K on time.</li>
<li>Hasbro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) gained 13.4% to $69.36 after the company reported better-than-expected quarterly financial results.</li>
<li>Shake Shack Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) rose 12.7% to $125.32 after the company reported quarterly EPS and revenue above estimates.</li>
<li>Bausch Health Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHC#NYSE">BHC</a>) gained 10.7% to $7.21 after the company reported better-than-expected quarterly sales.</li>
<li>Manulife Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFC#NYSE">MFC</a>) rose 7.3% to $31.96 after the company announced a dividend raise and a reduction in its shares outstanding through a normal course issuer bid.</li>
<li>STMicroelectronics N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) gained 6.2% to $28.13. The company is preparing to launch its next-generation technologies aimed at improving optical connections within data centers and AI clusters.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43851159/how-to-earn-500-a-month-from-newmont-stock-ahead-q4-earnings">How To Earn $500 A Month From Newmont Stock Ahead Of Q4 Earnings</a></li>
</ul>

Intraday Update

Markets

Movers

Trading Ideas

BABA

SHAK

Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday

WMT: -9% &#x7C; <a href="https://www.benzinga.com//node/43844271">Walmart shares are trading lower following soft Q1 guidance.</a>
&nbsp;
SHAK: 8% &#x7C; <a href="https://www.benzinga.com//node/43844159">Shake Shack shares are trading higher after the company reported Q4 EPS and revenue above estimates.</a>
&nbsp;
HFL: 24% &#x7C; <a href="https://www.benzinga.com//node/43843271">Herbalife shares are trading higher after the company reported Q4 EPS and revenue above estimates.</a>

Market-Moving News for February 20th

WIIM

Herbalife shares are trading higher after the company reported Q4 EPS and revenue above estimates.

Guidance

Herbalife Sees Q1 2025 Revenue (5.5%)-(1.5%) YoY

Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.22 by 63.64 percent. This is a 28.57 percent increase over earnings of $0.28 per share from the same period last year. The company reported quarterly sales of $1.20 billion which beat the analyst consensus estimate of $1.19 billion by 0.47 percent. This is a 1.23 percent decrease over sales of $1.22 billion the same period last year.

Earnings Beats

Herbalife Q4 2024 Adj EPS $0.36 Beats $0.22 Estimate, Sales $1.20B Beat $1.19B Estimate

Management

Herbalife Appoints Stephan Gratziani As Chief Executive Officer, Effective May 1

ACVA

AMPL

ANSS

APPN

BLCO

BMRN

BORR

CAKE

CCAP

CCSI

CHDN

CLVT

CMTG

CVNA

CWAN

ENLT

ENVX

ESRT

ETSY

EXAS

FOLD

First Trust Advantage Preferred Income Fund

FVRR

GLBE

GRAB

GRMN

HSBC

ICLR

IIPR

IMAX

INSG

IONS

KALU

KPTI

KRYS

KVYO

LAND

LILA

LILAK

LOPE

LUNG

MANU

MATV

MGRC

MTRN

NDSN

NRDS

NYMT

OBDC

PAAS

PERI

PNST

PRAA

Earnings Scheduled For February 19, 2025

Billionaire investor Bill Ackman praised Hindenburg Research&#8216;s contributions to capital markets following the influential short-seller&#8217;s unexpected closure, highlighting the firm&#8217;s crucial role in exposing corporate misconduct during <a href="https://www.benzinga.com/markets/equities/25/01/43018900/from-adani-to-nikola-how-hindenburg-research-reshaped-short-selling-before-its-final-bow">its seven-year run</a>.
What Happened: &#8220;This is a great letter from the founder of Hindenburg Research,&#8221; wrote Ackman, CEO of Pershing Square Capital Management, on X. &#8220;Short selling is really hard. Done well, when the research is shared publicly, it is a very important contribution to the proper functioning of the capital markets.&#8221;
The closure announcement <a href="https://www.benzinga.com/markets/equities/25/01/43022017/indias-second-richest-mans-conglomerate-rattled-by-hindenburg-researchs-damning-report-in-2023-adds-over-5-9-billion-after-short-seller-shuts-shop">triggered market reactions across companies</a> previously targeted by Hindenburg, with India&#8217;s Adani Group seeing its listed entities gain over $5.9 billion in market value on Thursday. New Delhi Television Ltd., an Adani-owned media company, surged 13% on Indian exchanges.
Founded in 2017 by Nathan Anderson, Hindenburg gained prominence after its 2020 investigation into Nikola Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) revealed the electric vehicle maker had staged a product demonstration video. The expose led to founder Trevor Milton&#8216;s conviction and four-year prison sentence for fraud.
&#8220;The shut down of Hindenburg Research is a big loss to the field. They have done some great work, which I have admired from a distance as we don't short stocks,&#8221; Ackman wrote. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is a great letter from the founder of <a href="https://twitter.com/HindenburgRes?ref_src=twsrc%5Etfw">@HindenburgRes</a>, <a href="https://twitter.com/NateHindenburg?ref_src=twsrc%5Etfw">@NateHindenburg</a>, about his decision to shut down his firm. Short selling is really hard. Done well, when the research is shared publicly, it is a very important contribution to the proper functioning of the capital…
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1880027354744906086?ref_src=twsrc%5Etfw">January 16, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
A user on X asked Ackman about shorting Herbalife Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>), to which he replied, &#8220;We retired from the short selling world after HLF.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We used to short stocks on occasion. A few over the first dozen years of the firm then we retired from the short selling world after HLF.
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1880050151903097076?ref_src=twsrc%5Etfw">January 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/43047487/teslas-drop-against-modestly-lower-nasdaq-comes-as-investors-weigh-elon-musks-40-50-billion-tiktok-deal-gary-black-says-tsla-share-swap-unlikely-due-to-this-upcoming-milestone">Tesla&#8217;s Drop Against Modestly Lower Nasdaq Comes As Investors Weigh Elon Musk&#8217;s $40-50 Billion TikTok Deal, Gary Black Says TSLA Share Swap Unlikely Due To This Upcoming Milestone</a>
Why It Matters: The firm&#8217;s most impactful investigation targeted India&#8217;s Adani Group in 2023, erasing more than $100 billion in market value and prompting U.S. prosecutors to indict founder Gautam Adani for alleged fraud. Hindenburg&#8217;s reports sparked nearly 100 civil and criminal charges against <a href="https://www.google.com/search?q=Hindenburg+Research+benzinga&amp;oq=hindenburg+research+benzinga&amp;gs_lcrp=EgZjaHJvbWUqCAgAEEUYJxg7MggIABBFGCcYOzIGCAEQRRhAMggIAhAAGA0YHjIICAMQABgNGB4yCAgEEAAYDRgeMgYIBRBFGDwyBggGEEUYPDIGCAcQRRg80gEINDkwNGowajSoAgCwAgA&amp;sourceid=chrome&amp;ie=UTF-8">various executives and companies</a>.
Anderson cited personal reasons for disbanding the 11-person firm. His departure follows other prominent short-sellers like Jim Chanos, who closed his hedge fund in 2023. Unlike traditional investment firms, Hindenburg managed only its own capital while publishing detailed research that often triggered regulatory investigations.
The firm&#8217;s final report on Jan. 2 targeted Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), alleging accounting irregularities, which the company denied. Anderson plans to spend six months documenting Hindenburg&#8217;s investigative methods to guide future market watchdogs.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/space/25/01/43046128/cathie-wood-adds-new-space-stock-to-2-etfs">Cathie Wood Adds New Space Stock To 2 ETFs: Company Went To Moon, Will Investment Returns Follow?</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Short Sellers

NKLA

Bill Ackman Says Hindenburg Research Closing 'A Big Loss,' Praises Short Seller's Contribution To Markets: 'Short Selling Is Really Hard'

Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) just disclosed its Q3 earnings on Wednesday, October 30, 2024 at 04:10 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Herbalife beat estimated earnings by 63.0%, reporting an EPS of $0.57 versus an estimate of $0.35.
Revenue was down $41.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
The company beat on EPS by $0.13 in the last quarter, resulting in a 9.0% drop share price change the following day.
Here's a look at Herbalife's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.35</td>
<td>0.41</td>
<td>0.34</td>
<td>0.39</td>
<td>0.73</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.57</td>
<td>0.54</td>
<td>0.49</td>
<td>0.28</td>
<td>0.65</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.24B</td>
<td>1.33B</td>
<td>1.26B</td>
<td>1.19B</td>
<td>1.25B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.24B</td>
<td>1.28B</td>
<td>1.26B</td>
<td>1.22B</td>
<td>1.28B</td>
</tr>
</tbody>
</table>

<h3>Peer Companies' Recent Earnings</h3>
As we review Herbalife's earnings, it's important to put its results into perspective by comparing them to those of its competitors, such as Honest Co, Beauty Health, and Veru.
<ul>
<li>Honest Co, earnings revealed on August 08, 2024, exhibited robust performance this quarter. Contrary to the market's projected EPS of $-0.04, Honest Co exceeded expectations with an EPS of $-0.04, reflecting an increase of 0.0% compared to estimates. This outcome is likely to gain investor confidence</li>
<li>The latest earnings report from Beauty Health on August 08, 2024 showed a downturn in performance, with results falling short of expectations. Despite the market's EPS estimate of $-0.05, Beauty Health reported an EPS of $-0.1, marking a -100.0% decrease.</li>
<li>Veru reported earnings on August 08, 2024 that fell short of expectations, with an actual EPS of $-0.07 compared to the market's estimate of $-0.06, resulting in a -16.67% decrease.</li>
</ul>
<h3>Reviewing Competitors' Quarterly Earnings and Stock Performance</h3>
In this detailed analysis, insights are provided into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>Herbalife</td>
<td>October 30, 2024</td>
<td style="text-align: right;">0.35</td>
<td style="text-align: right;">0.57</td>
<td>62.86%</td>
<td>$6.81</td>
<td>$7.29</td>
<td>7.05%</td>
</tr>
<tr>
<td>Honest Co</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.04</td>
<td style="text-align: right;">-0.04</td>
<td>0.0%</td>
<td>$3.24</td>
<td>$3.94</td>
<td>21.6%</td>
</tr>
<tr>
<td>Beauty Health</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.05</td>
<td style="text-align: right;">-0.10</td>
<td>-100.0%</td>
<td>$1.29</td>
<td>$1.0</td>
<td>-22.48%</td>
</tr>
<tr>
<td>Veru</td>
<td>August 08, 2024</td>
<td style="text-align: right;">-0.06</td>
<td style="text-align: right;">-0.07</td>
<td>-16.67%</td>
<td>$0.8101</td>
<td>$0.82</td>
<td>1.22%</td>
</tr>
</tbody>
</table>

<h3>Comparative Assessment: Estimated in Comparison with Actual Peer Revenues</h3>
This table presents a comparison of estimated and announced revenue figures for Herbalife's peers. It offers insights into the revenue performance of these companies, providing valuable context for understanding their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>Herbalife</td>
<td>1.24B</td>
<td>1.24B</td>
<td>0.0%</td>
</tr>
<tr>
<td>Honest Co</td>
<td>87.31M</td>
<td>93.05M</td>
<td>6.57%</td>
</tr>
<tr>
<td>Beauty Health</td>
<td>99.09M</td>
<td>90.60M</td>
<td>-8.57%</td>
</tr>
<tr>
<td>Veru</td>
<td>3.50M</td>
<td>3.95M</td>
<td>12.97%</td>
</tr>
</tbody>
</table>

To track all earnings releases for Herbalife <a href="https://www.benzinga.com/quote/HLF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Herbalife Q3 Earnings

Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-30. Here's what investors need to know before the announcement.
Analysts estimate that Herbalife will report an earnings per share (EPS) of $0.35. 
The market awaits Herbalife's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.13, leading to a 8.55% drop in the share price on the subsequent day.
Here's a look at Herbalife's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.35</td>
<td>0.41</td>
<td>0.34</td>
<td>0.39</td>
<td>0.73</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.57</td>
<td>0.54</td>
<td>0.49</td>
<td>0.28</td>
<td>0.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>11.0%</td>
<td>-9.0%</td>
<td>8.0%</td>
<td>-32.0%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730998929_0_0.png" alt="eps graph" />
<h3>Performance of Herbalife Shares</h3>
Shares of Herbalife were trading at $8.46 as of November 06. Over the last 52-week period, shares are down 34.98%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/HLF/earnings">To track all earnings releases for Herbalife visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Herbalife's Earnings Outlook

Mizuho analyst John Baumgartner maintains Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) with a Neutral and raises the price target from $8 to $9.

Mizuho Maintains Neutral on Herbalife, Raises Price Target to $9

DA Davidson analyst Linda Bolton Weiser maintains Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) with a Neutral and lowers the price target from $13 to $7.5.

DA Davidson Maintains Neutral on Herbalife, Lowers Price Target to $7.5

Herbalife shares are trading higher after the company reported better-than-expected Q3 financial results.

B. Riley Securities analyst Jeff Van Sinderen maintains Herbalife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLF#NYSE">HLF</a>) with a Buy and lowers the price target from $17 to $12.

B. Riley Securities Maintains Buy on Herbalife, Lowers Price Target to $12

Herbalife Expects Q4 Net Sales To Be (3.0)% To +1.0% YoY; Narrows FY24 Range To (2.0)% - (1.0)% YoY (Prior View (3.5)% To +1.5% )

Press Releases

Herbalife to Participate in Water Tower Research Fireside Chat on December 10

Herbalife Congratulates the LA Galaxy on Their MLS Cup Victory

Herbalife to Announce Fourth Quarter and Full-Year 2024 Results on February 19

Herbalife Appoints Stephan Gratziani as Chief Executive Officer

Herbalife Reports Q4 Net Sales at High End of Guidance, Q4 and Full-Year Net Sales Growth Excluding FX Headwinds1; Q4 Adjusted EBITDA2 Exceeds Guidance

Herbalife to Fuel Desert Smash 2025 As First-Ever Nutrition Sponsor

Herbalife to Acquire Assets of Pro2col Health and Pruvit Ventures, and Controlling Ownership Interest in Link BioSciences

Herbalife Fuels the Women's College All-Star Game as Official Nutrition and Hydration Sponsor

Herbalife to Announce First Quarter 2025 Results on April 30

Herbalife Renews Its Support for the LA Galaxy Special Olympics Unified Team for the 2025 Season

Comments

Herbalife

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO